Capitalization 11.74B 1.61B 125B P/E ratio 2024 *
18.3x
P/E ratio 2025 * 14.5x
Enterprise value 13.15B 1.81B 140B EV / Sales 2024 *
5.89x
EV / Sales 2025 * 4.48x
Free-Float
57.6%
Yield 2024 *
2.53%
Yield 2025 * 3.24%
More valuation ratios * Estimated data
Dynamic Chart
1 day-3.95%
1 week+2.39%
Current month-2.88%
1 month-9.48%
3 months-19.15%
6 months-17.02%
Current year-27.10%
More quotes
1 week
94.37
Extreme 94.37
100.16
1 month
92.00
Extreme 92
110.48
Current year
92.00
Extreme 92
133.93
1 year
92.00
Extreme 92
141.14
3 years
89.29
Extreme 89.2886
229.53
5 years
85.15
Extreme 85.1544
322.15
10 years
67.79
Extreme 67.7852
322.15
More quotes
Manager TitleAgeSince
Chief Executive Officer 43 30/06/18
Director of Finance/CFO 44 27/10/21
Director/Board Member 44 30/06/14
Director TitleAgeSince
Chairman 56 30/07/18
Director/Board Member 47 30/07/18
Director/Board Member 56 30/07/18
More insiders

Medical Devices & Implants

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-3.95%+2.39%-19.00%-57.33% 1.68B
-0.19%+2.49%+15.61%+30.10% 130B
+0.59%+3.76%-8.39%-29.08% 12.34B
-5.02%-2.87%-49.55%-68.96% 7.03B
+2.04%-0.33%+67.35%+150.96% 6.7B
-2.51%-4.56%-54.72%-22.13% 4.24B
+0.25%+0.25%+26.33%+2.85% 3.47B
+0.48%-0.78%-29.43%-66.06% 2.51B
-2.06%-1.06%-14.47%-32.06% 1.92B
-3.74%-1.39%-21.24%-60.21% 1.46B
Average -1.41%-0.94%-8.75%-15.19% 17.18B
Weighted average by Cap. -0.37%+1.75%+10.07%+20.95%
See all sector performances

Financials

Ratios2024 *2025 *
Net sales 1.54B 211M 16.37B 1.95B 268M 20.74B
Net income 635M 87.32M 6.77B 802M 110M 8.54B
Net Debt -2.7B -371M -28.76B -3.02B -415M -32.15B
More financial data * Estimated data
Logo Shanghai MicroPort Endovascular MedTech Co., Ltd.
Shanghai MicroPort Endovascular MedTech Group Co Ltd, formerly Shanghai MicroPort Endovascular MedTech Co Ltd, is a China-based company principally engaged in the research and development, production and sales of aortic and peripheral vascular interventional medical devices. The Company's main products include the aortic stent graft system for aortic minimally invasive interventional procedures, the intraoperative stent system for open surgery, as well as the peripheral vascular stent system and peripheral balloon dilatation catheters for the treatment of peripheral vascular diseases. The Company mainly distributes its products to the domestic market.
Employees
908
More about the company
Date Price Change Volume
23/07/24 95.23 ¥ -3.95% 1,716,235
22/07/24 99.15 ¥ +2.32% 2,137,279
19/07/24 96.90 ¥ +0.59% 1,690,503
18/07/24 96.33 ¥ +1.03% 1,545,273
17/07/24 95.35 ¥ +2.52% 1,998,104

End-of-day quote Shanghai S.E., July 22, 2024

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
95.23CNY
Average target price
162.79CNY
Spread / Average Target
+70.95%
Consensus
  1. Stock Market
  2. Equities
  3. 688016 Stock